Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$267.08
▼ $2.04 (−0.76%) today
Markets closed · 7:54am ET

JNJ Coverage

Page 89
7:13am ET
Health and Healthcare

J&J Earnings: Size Does Matter (JNJ)

Johnson & Johnson (NYSE: JNJ) is showing that some companies can get it right despite tough times.  The company has beat earnings and is even raising its fiscal 2008 guidance.  The consumer…

JNJ
Douglas A. McIntyre
7:08am ET
Investing

Johnson & Johnson (JNJ) Beats

The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare,…

JNJ
Douglas A. McIntyre
5:47am ET
Health and Healthcare

Abbott (ABT): A Resurrection Of The Stent Business

The stent business in the US has been dying and it is in trouble overseas. Stents are small mesh tubs which keep clogged arteries open. Last year, several studies showed that stents…

Douglas A. McIntyre
11:26am ET
Health and Healthcare

Another Stent Failure For Boston Scientific (BSX)

Investors have another reason to bail out of Boston Scientific (BSX). It has been in a battle with the medical research community for over a year fighting the perception that its drug-coated…

Douglas A. McIntyre